EPO Patent EP3601341A1: Antibodies Against Human FSHR Extracellular Domain

The European Patent Office has published patent application EP3601341A1 concerning antibodies against the human FSHR extracellular domain. The patent is assigned to FSHR Theranostics and lists Nicolae Ghinea as the inventor. The publication date is March 11, 2026.

EPO Patent EP3727468A1: AAV-mediated delivery of therapeutic antibodies to inner ear

The European Patent Office has published patent application EP3727468A1 concerning AAV-mediated delivery of therapeutic antibodies to the inner ear. The patent is assigned to Akouos, Inc. and lists Emmanuel J. Simons, Robert Ng, and Michael McKenna as inventors.

Patent EP3690038A1: Antibody Pyrrolidobenzodiazepine Derivative Conjugate

The European Patent Office has published patent application EP3690038A1 for an "Antibody Pyrrolidobenzodiazepine Derivative Conjugate" filed by Daiichi Sankyo Company, Limited. This publication relates to a new class of therapeutic compounds.

EPO Patent Bulletin - Hybridoma Clones and Monoclonal Antibodies

The European Patent Office has published patent application EP3645042A2 concerning hybridoma clones, monoclonal antibodies to Vsig-4, and methods of making and using them. The patent is assigned to Bio-Techne Corporation and lists multiple inventors.

EPO Patent Bulletin: Stable Formulations of Antibodies to PD-1

The European Patent Office has published patent application EP3398612A1 concerning stable formulations of antibodies to human programmed death receptor PD-1 and related treatments. The application was published on March 11, 2026, with Merck Sharp & Dohme LLC listed as the applicant.

Regeneron Pharmaceuticals Cell Depletion Patent EP3471772A1

The European Patent Office has published patent application EP3471772A1 for Regeneron Pharmaceuticals, Inc. concerning compositions and methods for the depletion of cells. The patent application was published on March 11, 2026.

Patent EP3468587A1 for Cancer Biomarker Detection

The European Patent Office has published patent application EP3468587A1 concerning monoclonal antibodies, compositions, and methods for detecting mucin-like protein (MLP) as a biomarker for ovarian and pancreatic cancer. The patent is assigned to the University of Leicester and Omeros Corporation.

EPO Patent Publication: Fish Skin Collagen Peptides Composition and Drug Use

The European Patent Office has published patent application EP3532491A1 concerning the composition of fish skin collagen peptides and their use as a drug. The publication details the applicants and inventors associated with this patent.

Patent EP3515945A1: Anti-STEAP2 Antibodies, Drug Conjugates, Uses

The European Patent Office has published patent application EP3515945A1 concerning anti-STEAP2 antibodies, antibody-drug conjugates, and their uses, filed by Regeneron Pharmaceuticals, Inc. The patent application details specific molecular entities and their therapeutic applications, particularly in oncology.

EPO Patent Publication: BAFF-R Targeted CAR T-cells

The European Patent Office published patent application EP3464371A1 on March 11, 2026, concerning BAFF-R targeted chimeric antigen receptor-modified T-cells and their uses. The patent application lists City of Hope and The University of Texas System as applicants.